Preliminary results from the phase-one trial indicate promise for patient safety and positive patient outcomes.
The company expects to commence enrollment in the randomized, double-blinded, placebo-controlled trial in the fourth quarter of 2012. Interim results are expected by the end of 2013.
More Articles on Orthopedic Devices:
Globus Medical to Showcase New Spine Surgery Products
Paradigm Spine, OM HealthCare Sign Multiyear Logistics Agreement
Integra LifeSciences Launches Complete Cervical Interbody Fusion Device
